Recruiting Lung Cancer Studies in Toledo
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
The purpose of this study is to evaluate the safety and efficacy of zipalertinib in combination with standard first-line platinum-based chemotherapy compared to chemotherapy alone, in patients with lo...
About Lung Cancer Clinical Trials in Toledo
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Toledo, OH. These studies are seeking a combined 967 participants. Research is being sponsored by Gilead Sciences, Taiho Oncology, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Toledo — FAQ
Are there lung cancer clinical trials in Toledo?
Yes, there are 2 lung cancer clinical trials currently recruiting in Toledo, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Toledo?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Toledo research site will contact you about next steps.
Are clinical trials in Toledo free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Toledo studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Toledo are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov